Yosuke Inukai
Papers
1
Total Citations
3
H-Index
1
About
Dr. Yosuke Inukai is a leading interventional radiologist whose research focuses on advancing locoregional therapies for hepatocellular carcinoma (HCC), particularly through the optimization of transarterial chemoembolization (TACE). His major contribution lies in pioneering the clinical application of a porous glass membrane-pumping emulsification device (GMD), which generates a high-percentage water-in-oil emulsion with remarkably homogeneous and stable droplets. This innovation directly addresses a critical limitation of conventional TACE—inconsistent drug delivery—by enabling more uniform and sustained embolization. In his landmark 2022 study on solitary HCC, Dr. Inukai demonstrated that GMD-assisted TACE significantly improves locoregional therapeutic effects, a finding that has garnered attention with 3 citations and is shaping next-generation interventional oncology protocols. His work bridges materials engineering and clinical oncology, offering a tangible path to enhanced tumor response while minimizing hepatic toxicity. Dr. Inukai’s research is particularly impactful for students and clinicians seeking to understand how precision engineering can refine standard cancer therapies, and his ongoing investigations promise to further elevate the standard of care in hepatic malignancy management.
Research Focus
Key Achievements
Top Papers
- 1